Pacgen Life Science Corporation announced management changes. Ms. Christina Yip, Mr. Ivan Wong, Mr. Sudhir Sharma and Ms. Andrea Chan have been appointed as Chief Executive Officer, Executive Vice President, Operations, Executive Vice President, Business Development, and Interim Chief Financial Officer, respectively. Mr. Chung Yu Wang, Chairman of the Board, has resigned from his interim CEO position to focus his leadership role at the Board level.

The new management appointments are part of Pacgen's continued efforts to build an international commercial platform to sell, market and distribute innovative consumer health products developed by small business enterprises. It has recently created distribution hubs in Taipei and Delhi, and signed collaborative agreements with companies based in South Korea and Hong Kong toward upcoming product launches. The Company currently has sale and distribution rights to four distinctive brands with over seventy personal care products.

Prior to joining Pacgen, Mr. Sharma held senior engineer positions with multinational companies headquartered in Japan, India, Germany, USA and Canada.  Mr. Sharma currently also serves as a director of 3A International Technology Inc., where he oversees and provides guidance to multiple start-up ventures in business development and product penetration into the South Asian markets. Mr. Wong has more than 15 years of experience in leading and managing customer support operations in the healthcare IT sector, primarily with McKesson Corporation (“McKesson”), following an entrepreneurial experience in his early career.  At McKesson, he has led many change management and continuous improvement projects.